Whole Exome Sequencing (WES) from DNA of all 23,000 genes

 Whole Transcriptome Sequencing (WTS) from RNA of all 23,000 genes

These panels test a wide range of genes associated with epilepsy syndromes, including generalized and focal epilepsies.

Focuses on genes linked to early-onset epilepsies, such as infantile spasms and early infantile epileptic encephalopathies.

Targets genes associated with focal (partial) epilepsy, where seizures originate from a specific area of the brain.

Concentrates on genes linked to generalized epilepsy, where seizures involve both sides of the brain from the onset.

Includes genes associated with severe epilepsy syndromes that impact cognitive function, such as Dravet syndrome, Lennox-Gastaut syndrome, and other severe forms.

Targets genes involved in myoclonic epilepsy syndromes, including myoclonic-astatic epilepsy and juvenile myoclonic epilepsy.

Focuses on genes linked to febrile seizures and febrile seizure plus syndromes.

Analyzes genes associated with progressive myoclonus epilepsies, which are rare, genetic, and often degenerative disorders.

Includes genes related to ion channel disorders that can lead to epilepsy, such as SCN1A, KCNQ2, and others.

CANLYTx™ (CANCER + ANALYTICS) is a molecular data analytics and simulation engine that explores the whole exome data of the patient’s tumor. Comprehensive Genomic Profiling (TMB+MSI+ HRR +PD-L1) NGS Test That Detects 517 Solid Tumour Biomarkers